Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904969 · ClinicalTrials.gov registry record · NA
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A NA study, sponsored by American Medical Systems.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT00904969: Completed NA study, sponsored by American Medical Systems.
NCT00904969 is a NA study that has completed, run by American Medical Systems. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904969, a NA study, has completed, sponsored by American Medical Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain surgical technique data for use in physician education and training and to collect early clinical outcomes data for future publication.
Primary Outcome
Characterize procedure time from first incision to closing.
Interventions
- DEVICE The AMS Male Transobturator Sling System
- DEVICE AdVance Male Sling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT00904969 record still lists
NCT00904969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which The AMS Male Transobturator Sling System is the first listed.
NCT00904969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00904969 about?
NCT00904969 is a clinical study titled "A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence". The purpose of this study is to obtain surgical technique data for use in physician education and training and to collect early clinical outcomes data for future publication.
What is the current status of trial NCT00904969?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2005-09. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00904969?
The interventions under investigation include: The AMS Male Transobturator Sling System (DEVICE), AdVance Male Sling (DEVICE).
Who is sponsoring clinical trial NCT00904969?
This trial is sponsored by American Medical Systems, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00904969's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia